GSK-3β inhibitor, 9-ING-41, reduces cell viability and halts proliferation of B-cell lymphoma cell lines as a single agent and in combination with novel agents
Reem Karmali*, Vineela Chukkapalli, Leo I. Gordon, Jeffrey A. Borgia, Andrey Ugolkov, Andrew P. Mazar, Francis J. Giles
Dive into the research topics of 'GSK-3β inhibitor, 9-ING-41, reduces cell viability and halts proliferation of B-cell lymphoma cell lines as a single agent and in combination with novel agents'. Together they form a unique fingerprint.